Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: a short

A Greystoke1, G Harris, M Jenkins

  • 1Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK. agreystoke@picr.man.ac.uk